




1078–5884/00Embolization-driven Occlusion of the Abdominal Aortic
Aneurysmal Sac as the Basis of Prevention of Endoleaks
in a New Swine Model
P.H. Rolland,* V. Vidal, C. Mekkaoui, M.-F. Bertrand, O. Levrier and J.-M. BartoliLaboratory of Hemodynamics and Cardiovascular Mechanics, School of Medicine, La Timone Hospital for
Adults, Mediterranean See University and Department of Radiology, Marseilles, FranceObjectives. To assess the effect of a new polymer in embolization of endoleaks using an animal model.
Methods. A modified aortic stent-graft was placed in 20 pigs. Embolization was performed at the time of graft insertion
with non-cytotoxic n-butyl-2-cyanoacrylate-metacryloxysulpholane and lipiodol (0.2:0.8ratio, 2 ml). Angiography,
scanning electron microscopy and immuno-histochemistry were obtained at day 0, 1 week and 3 months.
Results. In control animals both type I and II endoleaks were demonstrated. In treated animals, neither type-I nor type-II
endoleaks were observed and a fibro-proliferative response was demonstrated within the aneurysm thrombus.
Conclusions. Host vascular responses govern the fate of the excluded aneurysm. Embolization of the sac and feeding arteries
with non-cytotoxic glue sealed all occlusions by stimulating a massive restenosis-like process.Keywords: Porcine experimental models; Abdominal aortic aneurysm; Endovascular aneurysm repair; Endoleaks;
Embolization; Aneurysm sac occlusion.Introduction
Continued pressurization of the aortic sac following
endovascular aneurysm repair (EVAR) of abdominal
aortic aneurysm (AAA) has been associated with
subsequent rupture.1–8 Types I and II endoleaks are
due to insufficient sealing at the graft ends or from
retrograde collateral inflow via lumbar arteries and the
inferior mesenteric artery (IMA).8–11 Type I endoleaks
are acknowledge to be dangerous, however, type II
endoleaks have also been associated with aortic
rupture and may facilitate the development of the
former.1–4,8,9,11–15 A number of approaches have been
used in an attempt to embolize aortic branch vessels
and prevent endoleak development.4,16–23 One tech-
niques is to inject liquid cyanoacrylate adhesives with
anionic polymerisation, however, these agents appear
to be toxic and damage the vascular intima.24–26
Subsequent foreign-body responses can lead to vessel
wall enlargement and neovascularization.25,26 We
previously reported the therapeutic efficacy ofing author. Pierre H. Rolland, PhD, LHMCV, School of
diterranean See University, 27, Bld Jean-Moulin, 13385
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standard n-butyl 2-cyanoacrylate monomers plus
metacryloxysulpholane monomers, whose presence
converts the polymerization pathway from an ionic to
a radical mechanism which is a non-cytotoxic.26 In this
experimental study we investigate the non-cytotoxic
embolization of the aortic aneurysm sac and feeding
arteries following endo-grafting. We used an exper-
imental porcine model creating by placing an endo-
luminal graft which occupied only around 50% of the
aortic lumen leaving an external sac similar to
endovascular repair of human AAA.Materials and MethodsExperimental protocol
The Ethics Committee granted approval for the present
protocol. Twenty (controls, nZ8; embolized, nZ12)
5-months old, male Pietrin swines (45G6 kg) (Blos-
sinSA, Aubagne, France) were fed a standardized diet
for pregnant sows to minimise weight gain (weight at 3
months 56G7 kg).19,26,27 Pigs were anesthetized with
ketamine (15 mg/kg, IM) and midazolam (Hypnovel,Eur J Vasc Endovasc Surg 31, 28–35 (2006)
doi:10.1016/j.ejvs.2005.07.018, available online at http://www.sciencedirect.com onved.
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cillin–clavulanic acid, 1 g:200 mg in 20 ml, IV) were
given before and after the procedures.27–30 The animals
were euthanized with midazolam (50 mg in 10 ml), and
chlorpromazine (25 mg) in 25 ml KCl 20% (w/v, bolus,
IV).Endoluminal aortic procedures
Stents, stent-grafts, delivery devices, and catheters
were provided by Boston Scientific Corporation,
Natick, USA. A custom made device incorporating a
prosthesis (100!10 mm,Vanguard) and a Symphony
nitinol stent (20!6 mm) placed inside a 12F introducer
sheath (34 cm-long) was created.20 A digital subtrac-
tion angiography system (GEMedical-System, Minnea-
polis,USA) was utilized for the procedures.20,27
Percutaneous access was gained in both superficial
femoral arteries (SFA) (11 cm 5F vascular sheaths). Pre-
and post-procedure angiograms were obtained (Hex-
abrix, Guerbet Inc., 25 ml, 14 ml sK1) via pigtail
angiographic catheters (5F, 100 cm, tip with 1 cm-
distant radiopaque markers) in the abdominal aorta.
Dimensions and localization of the aorta and collaterals
(renal and lumbar arteries) were computerized from
the frames.31 Via the left SFA, two Excelsior micro-
catheters (2.6F, 150 cm, 2.0F terminal part) were
advanced into the mid (to deliver the embolisation
material) and suprarenal aorta. The 5F sheath in right
SFAwas substituted for a 14 F introducer sheath and the
stent-graft delivered to the infra-renal aorta. Pre-
embolization angiograms of aorta and AAA sac (3 ml
pure contrast-agent) were obtained. The microcatheter
was connected to a 5-ml Luer-locked syringeFig. 1. Final intraoperative angiograms of the abdominal a
endoprosthesis placement (early angiographic phase); and of th
placed before endograft placement. At 3 months, anteroposteri
lumbar arteries below the stent-graft and the late-phase retrog(Medallion, Merit Medical, South Jordan, Utah) and
flushed with isotonic 5% glucose solution. Glubran2
(GEM-Viareggio, Italy) glue was homogenized with
ultrafluid lipiodol (Guerbet Lab, Aulnay/Bois, France)
at 0.2:0.8 v/v proportions.26 A 2 ml volume of the
mixture was injected in a four-step procedure inter-
spersed with flushing with isotonic glucose. Following
digital haemostasis of the left SFA, and surgical closure
of the right SFA, the animals were transferred to the
post-operative holding room to recover. Further trans-
carotid angiograms were obtained 30 min post-pro-
cedure, day 7, and 3 months. In contrast to humans, pig
spinal cord extends to the fifth lumbar vertebra. To
prevent neurological events in the swine, the following
pre- and post-implantation anticoagulant protocol was
delivered: sodium heparin (10,000 IU in 1 ml, bolus)
was given IV. before 6F–14F sheath replacement and
after the embolization procedure; then, calcium-
heparin (10,000 IU in 0.8 ml) was given subcu-
taneously, twice a day for 3 days, and finally the
animals received calcium nadroparine (7600 IU antiXa
in 0.8 ml) daily subcutaneously for a further 3 days.Histology, scanning electron microscopy and morphometry
Following midline laparotomy, the stented segment
from the abdominal aorta down to the iliacs arteries
was sampled.26–30 Specific attention was given to the
lumbar arteries up to the backbone. Further catheter-
isation of the aorta was performed with a 22G
intravenous catheter for repeated washings and
perfusion with ph 7.3 buffered 10% formalin for fixation
under a 120 mmHg pressure (15 min). Samples were
fixed for 48 h, prior to being cut-open longitudinallyorta, (a) showing reduction of the aortic lumen due to
e aneurismal sac and lumbar arteries, (b) from microcatheter
or aortogram shows the early-phase anterograde flow, (c) of
rade, (d) lumbar flow to the aneurysm sac.
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Fig. 2. Anteroposterior arteriograms obtained from selective
positioning of the angiographic catheter tip above the upper
neck of the endoprosthesis in control swines, at 3 months. A
small right perigraft leakage demonstrated type II endoleak
(left), the contrast media trace progressed in a retrograde
manner from the patent lumbar branchs, to caudally feed the
sac. The type I endoleak inflow (right) originated from the
upper neck in the juxtarenal position, and it progressed
ventrally to the proximal portion of the sac to feed the type II
endoleak, and finally the egress of twisted type II endoleak
was through both IMA and circulating lumbar arteries at the
caudal endings of the sac. No distal type I endoleak was
detected.
P. H. Rolland et al.30with a tungsten carbide scissors, with one half being
processed for scanning electron microscopy (SEM), and
second half for histology examination.20,26,29–31 Long-
itudinally sectioned (5 mm) were cut from paraffin
embedded samples. Samples for SEM examinations
were either dehydrated in progressive alcohols orFig. 3. Photographs from SEM investigations of transverse (left
graft-stented aorta in a control animal at 3 months. The patent
(AoW) by the endoprosthesis (Ep), the type II endoleak (El2) an
feeding lumbar artery (LA). The inner walls of the type II end
Eur J Vasc Endovasc Surg Vol 31, 1 2006submitted to sputter coating with 30 nm gold prior to
examination in the Quanta 200 SEM (FEI company,
Eindhoven, The Netherlands) under low vacuum
mode 1 Torr with water vapour.
Immunohistochemical staining for von Willbrand,
FactorVIII and SMC-specific alpha-actin was per-
formed on rehydrated deparafinized (5 mm) serial
slides with appropriate blocking serum using rabbit
or mouse monoclonal primary antibodies, and horse-
radish peroxidase or alkaline phosphatase enzymatic
conjugates to the appropriate secondary antibodies
with DAB or fast-red chromogen substrates.28–31
When required, antigen retrieval using pepsin sol-
ution digests was carried out. All reagents were from
Zymed Laboratories Inc (CA 94080, USA).ResultsStent implantation and angiographic findings
The stent-grafts were placed with optimal immediate
results in all cases, and no acute complications
occurred during glue-lipiodol solution delivery. A
single animal (control group) developed paraplegia on
day 1 and died at day 8. Seven control (sacrificed at
day 1, nZ1, and 3 months, nZ6) and twelve
embolized (sacrificed at day 0, nZ3, at week 1, nZ3,
and at 3 months, nZ6) swines completed the study.) and longitudinal (right) sections of the aneurysm sac in the
aortic lumen (AoL) is separated from the aortic vascular wall
d the aneurysm sac (sac). The endoleak was connected to the
oleak was covered by endothelial cells.
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diameter were 9.85G0.26 and 9.75G0.45 and 110.62G
4.25 and 105.43G5.32 mm in length. The luminal
constricted diameter of aorta was 5.88G0.54 and
5.53G0.42 mm pre and post stenting, respectively,
(Fig. 1). At 3 months, the upper aortic neck was 9.98G
0.35 and 10.15G0.29 mm in diameter in the grafted
and graft-embolized groups. There was no significant
difference in any of these diameters. No displacement
of the grafts was noted by the end of the protocol. Late
retrograde feeding of control AAA persisted via the
lumbar arteries (Fig. 1).The control aneurysm
At 3 months angiography demonstrated persistent
type II endoleak in all control animals (Fig. 1). ThreeFig. 4. Microphotographs of the aneurysm sac and aortic wall in
embedded the type I endoleak (El2) and secondary endothelia
vascular smooth muscle (VSMC) alpha-actin in transverse sac-A
from AoW, as crossing of the internal elastic lamina (black arr
arrow) developed paralleling the sac contours, (c) HE-staining
blood cells close to aortic intima and in AoW, (d) fast-red immu
actin in transverse sac-Aow section further shows the absence
lacunae emergence progressed in procession through the thro
Horseradish peroxydase-based immunohistochemistry dire
demonstrates the endothelial nature of the cells underlining thendoleaks were lateral to the aortic prosthesis (Fig. 2)
and three were ventral. The endoleak channels were !
2 mm in diameter. Proximal type I endoleaks were
demonstrated in two cases (Fig. 2). In each animal,
outflow from the aneurysm was to the lumbar arteries
and collaterals and in the two animals with type I
endoleaks, the outflow path also involved the inferior
mesenteric artery (Fig. 2). SEM in the control
aneurysms at 3 months (Fig. 3) revealed the spatial
organization of the type II leaks. Within organized
thrombotic clots (fibrin fibers reinforced with collagen)
and fibrocellular processes, the flow channel in the sac
consisted of a thin, flat, free space with a curved shape
paralleling the aneurysm crown concavity. The flow
path passing through the organized thrombotic clots
in the sac was lined by a monolayer of endothelial cells
typical of neo-vascularisation.control animals at 3 months, (a) the aneurysm sac materials
l lined spaces (arrow), (b) fast-red immunohistochemistry of
ow section demonstrates that the sac was invaded by VSMC
ow); and fibrocellular processes from myofibroblasts (white
of the sac-AoW section shows small organized vessels with
nohistochemistry of vascular smooth muscle (VSMC) alpha-
of VSMC in the thrombotic materials; endothelial-cell lined
mbotic materials from the intima of AoW (white arrow), (e)
cted against FVIII-related antigens of endothelial cells
e lacunae within the sac thrombotic materials.
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Fig. 5. 3D-reconstruction of embolized AAA at d0 (left).
Aortic angiograms (right, late-phase) in animal with
embolized aneurysm at 3 months show the persistent
occlusion of embolized lumbar arteries (white arrows)
despite the anterograde feeding of vicinal lumbar arteries.
P. H. Rolland et al.32Histology and immunohistochemistry observations
further supported neo-vascularisation with endo-
thelial-lined spaces of variable size from simple
elementary lacunae to organized vessels containing
red cells (Fig. 4). Smooth muscle cells (positive for
alpha-actin) and myofibroblasts were present within
the thrombus.Fig. 6. Macroscopic appearances of the subrenal aorta at 3 mon
upper panel, right insert) showing the aneurysm, and from an em
whole mass of glue adhering to arterial wall up into the ostium
Eur J Vasc Endovasc Surg Vol 31, 1 2006The embolized aneurysm
Complete embolization was achieved in each case by a
four-step delivery of glue (2 ml final volume) within
225G21 s. Typical tri-dimensional AAA reconstruc-
tion at day 0 and macroscopic appearance at 3 months
are shown in Figs. 5 and 6, respectively. At 3 months,
all grafted abdominal aorta were patent with no
endoleaks (Fig. 5). Macroscopic examinations of long-
itudinally cut-opened abdominal aorta revealed that
the non-embolized sac was entirely filled with only
fresh thrombus at day 0, with both fresh and
transformed thrombus at 1 week, and at 3 months
there were substantial areas of solid fibrosclerotic
material (Fig. 6). SEM in longitudinally cut-opened
abdominal aorta (Fig. 7) showed that the glue
polymerized slowly and hardened without fragmenta-
tion. The low reactivity and adhesive forces of the glue
accounted for the presence of glue casts of the
endoprosthesis and vascular walls without injuring
either of them. At 1 week, the aneurysm was filled by
the glue and organized fibrin deposits. At 3 months,
the integrity of glue masses was preserved while the
thrombus was replaced by a dense fibrocellular
response. Histological examinations of the abdominal
aorta, aneurysms sac and lumbar arteries in embolized
animals confirmed the progressive fibrocellular
response (Fig. 8). At day 0, the post-procedure
occlusive process consisted of a plug made of the
glue-lipiodol mixture embedding fresh thrombotic
materials, sparsely attached to the intima, but without
injuring the vascular wall (Fig. 8(A)). At 1 week,ths from a control, non-embolized animal (cut-opened artery,
bolized animal (closed prosthesis, lower panel) showing the
of lumbar arteries.
Fig. 7. Photographs from SEM investigations of the embolized AAA space show at day 0 budding of glue masses ((A) and
(B)), closely adherent to vascular walls (C), with preservation of intima and internal elastic laminae, endoprosthesis cast (D),
mixing of glue (left) and advanced thrombotic processes (right) at 1 week (E), and replacement of thrombotic clots by
fibroproliferative materials, at 3 months (F).
Cell-Based Occlusion of Aneurysmal Sac 33the advanced thrombus, further converted to fibrils
and clusters of fibrin, was embedded within the glue
mass, and the arterial wall remained underlined by a
thin fibrin film. The absence of fresh thrombus
indicates that there was no longer blood circulation
in the aneurysm and lumbar arteries (Fig. 8(B)). At
3 months, the luminal space was filled with a
fibrocellular reaction due to proliferative myofibro-
blasts spreading from the arterial walls typical of
restenosis (Fig. 8(C)).Discussion
This study demonstrates that within a swine model of
endografting the aneurysm sac thrombus undergoes a
neo-vascular response which may support a type II
endoleak. The type II endoleak may encourage the
delayed development of a type I leak without
proximal neck enlargement. The use of low toxicity
glue was able to prevent endoleak development
possibly by altering the type of repair response. A
dense fibroproliferative response was evident in
embolised arteries rather than the neo-vascular
response seen in control animals.
The experimental model of aneurysm used was
designed as a strictly catheter-based model in order to
protect the infrarenal aorta and collaterals from
iatrogenic surgical interventions, thereby enabling
endoleak to be studied.6,16–20 The limitation of this
model is that the aneurysm did not increase in sizeover the mid-term, a process which may require a
longer time to develop, provided weakening of the
arterial wall actually occurs.3,4,8,21,32
The surprising development of proximal endoleak
in two out of six animals at mid-term, was associated
with maintained patency of the IMA and absence of
sac thrombus.
We previously reported the efficacy of embolization
of porcine renal and brain arteries by using a mixture
of standard n-butyl-2-cyanoacrylate (nb-CA) mono-
mers plus metacryloxysulpholane (MS) monomers
whose presence converts the polymerization pathway
from anionic to radical mechanisms.26 The radically
formed nb-CA casts poorly gripped and attached to
the intima without injury, and finally embolized
arteries presented without inflammatory crown sur-
rounding the adventitia.26 We report here that such
non-cytotoxic embolization occurred in the aneurysm
sac and the lumbar arteries by demonstrating that a
polymerization mechanism independent of the reac-
tive proteins in the vascular wall accounts for
adherence of non-crystalline casts of prosthesis to the
vessel walls. The non-cytotoxic embolization of the
aneurysm sac and its feeding lumbar arteries drove
aortic VSMCs and myofibroblasts to settle the
transformed fibrin clots into fibrosclerotic structures
embedding the glue masses. The concomitant resorp-
tion of lipiodol pockets by myofibroblasts enhanced
the available luminal space for spreading processes.
The aneurysm occlusion by proliferative SMCs
and large amounts of collagen and proteoglycan-richEur J Vasc Endovasc Surg Vol 31, 1 2006
Fig. 8. Microphotographs of histopathologic changes in
embolized lumbar arteries show the glue (Gl) masses
embedding thrombotic pockets (Th) and voids previously
filled with lipiodol (Li) in the absence of parietal injury
(LAW: lumbar arterial walls), at day (0); and organized
fibrino-sclerotic clots (Th) and fibrin (Fib) endothelial
underlining of LAW at 1 week (B); and restenotic-like
fibrocellular processes (FibC) colonizing the evanescent
lumbar lumen and surrounding glue (Gl) masses at 3
months (C).
P. H. Rolland et al.34extra-cellular matrix develops to the detriment of the
endothelial cell-mediated fibrinolysis and subsequent
neovascularization observed in the patent aneurysm
sac. One interesting pathological feature of the study is
the findings that the fibrin clots in the embolized
sac turned to transformed, stabilized fibrinosclerotic
clots, whereas thrombus in the control sac retain
the appearance of fresh thrombus made of non--
transformed fibrin, at 3 months. The former condition
was found to require myofibroblast spreading,20
whereas persistence of leaks and endothelial cell-
mediated fibrinolysis led to a continuous renewal of
fibrin clots. Our findings support the development
of techniques to inhibit neo-vascularisation ofEur J Vasc Endovasc Surg Vol 31, 1 2006the thrombus within the aneurysm sac after EVAR.
The clinical efficacy remains to be established.References
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